Three-month outcomes and cost-effectiveness of interferon gamma-1b in critically ill patients: a secondary analysis of the PREV-HAP trial
Author(s):
Marwan Bouras, Philippe Tessier, Cécile Poulain, Solène Schirr-Bonnans, Antoine Roquilly
Details:
Journal of Intensive Care, Volume 12, Issue 1, 2024-12-01, Article number 40
Article Link: Click here
Affiliations:
- CHU de Nantes
- The Peter Doherty Institute for Infection and Immunity
- Center for Research in Transplantation and Translational Immunology
- Hopital de la Cavale Blanche